ACM
XERS icon

AIGH Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

AIGH Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,574,846
Closed -$8.73M – 50
2024
Q4 		$8.73M Buy
2,574,846
+389,192
+18% +$1.25M 2.73% 16
2024
Q3 		$6.23M Buy
+2,185,654
New +$5.61M 1.76% 15

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AIGH Capital Management's XERS Position: Q1 2025 in Review

AIGH Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2025, closing a stake of 2,574,846 shares — an estimated $8.73M sold.

AIGH Capital Management first reported a position in XERS in Q3 2024 and held it in 2 quarters. The position peaked at $8.73M in Q4 2024. 199 funds tracked by Wall St. Rank hold XERS as of Q1 2025.

  • AIGH Capital Management reported no remaining Xeris Biopharma Holdings position as of Q1 2025 after selling out during the quarter.
  • AIGH Capital Management sold 2,574,846 Xeris Biopharma Holdings shares in Q1 2025, an estimated $8.73M.
  • AIGH Capital Management first reported a position in Xeris Biopharma Holdings in Q3 2024 and held it in 2 quarters.
  • AIGH Capital Management's Xeris Biopharma Holdings position peaked at $8.73M in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2025.

Based on AIGH Capital Management's 13F filing for Q1 2025, filed 6 May 2025.